Story perspectives

GCC Invests $34.6 Billion in Biotechnology Growth by 2040

10/27/2025

Summary

Story summary

Saudi Arabia's National Biotechnology Strategy targets US$34.6 billion to non-oil GDP by 2040, signaling a GCC biotech push.
The Gulf Cooperation Council (GCC) advances biotechnology and digital health as demographics and diversification drive investment.
Projections indicate the UAE's digital health market will grow more than 23% by 2030 to US$2.65 billion.
Initiatives such as pre-marital genetic testing and population mapping are expanding precision medicine, while research infrastructure and data governance remain challenges.

1 of 1

Story summary

Saudi Arabia's National Biotechnology Strategy targets US$34.6 billion to non-oil GDP by 2040, signaling a GCC biotech push.
The Gulf Cooperation Council (GCC) advances biotechnology and digital health as demographics and diversification drive investment.
Projections indicate the UAE's digital health market will grow more than 23% by 2030 to US$2.65 billion.
Initiatives such as pre-marital genetic testing and population mapping are expanding precision medicine, while research infrastructure and data governance remain challenges.